Translating research into clinical care
Complex issues such as depression and suicide require complex solutions. While the stigma associated with mental illness may be decreasing, those who seek help may not find effective care. To improve patient outcomes, The Royal has established two research centres where clients with difficult-to-treat depression can receive access to novel treatments that can change the trajectory of their lives.
- Esketamine
-
A nasal form of ketamine that quickly alleviates symptoms of depression and suicidal thoughts. Learn more about esketamine here.
- Repetitive transcranial magnetic stimulation (rTMS)
-
A non-invasive treatment targeting malfunctioning circuits in the brain. Learn more about rTMS here.
Suicide is preventable
Suicide is the ultimate human cost of mental illness. With greater understanding of the biology of depression and suicide ideation, we can prevent it. However, we cannot do it alone.
Your support today can save lives. Now that you know, what will you do?